The Role of EBUS-TBNA in the Diagnosis and Staging of Lung Cancer

Um, Sang-Won

doi:10.7599/hmr.2014.34.1.20

Review Article

Open Access


Hanyang Med Rev. 2014 Feb;34(1):20-25. Korean. Published online February 25, 2014. https://doi.org/10.7599/hmr.2014.34.1.20
© 2014 Hanyang University College of Medicine


The Role of EBUS-TBNA in the Diagnosis and Staging of Lung Cancer
Sang-Won Um
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Correspondence to: Sang-Won Um. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea. Tel: +82-2-3410-3429, Fax: +82-2-3410-3849, Email: sangwonum@skku.edu

Received November 01, 2013; Revised January 13, 2014; Accepted January 21, 2014.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article has been cited by 1 article in This article has been cited by 1 article in KoMCI. This article has been cited by Google Scholar.
Go to: Abstract
Convex-probe endobronchial ultrasound-guided transbronchial needle aspiration (CP-EBUS-TBNA) has emerged as a new diagnostic modality that allows ultrasound-guided, real-time needle aspiration of mediastinal and hilar lymph nodes. Mediastinoscopy has been the reference standard for neoplastic staging in the mediastinum, but it is invasive and requires general anesthesia. Considering recent prospective studies and clinical guidelines, a needle technique such as EBUS-TBNA and endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) should be performed first for the mediastinal nodal staging of non-small lung cancer. Combining EBUS-TBNA and EUS-FNA will replace more invasive methods such as mediastinoscopy. CP-EBUS-TBNA can also be used for the restaging after neoadjuvant therapy, the diagnosis of recurrent lung cancer and central lung parenchymal lesion which abuts trachea or bronchi. In the era of personalized medicine, good-quality and sufficient tissues need to be obtained for the molecular testing and treatment guidance. EBUS-TBNA has the ability to obtain satisfactory material for the detection of EGFR mutation, KRAS mutation, and EML-ALK fusion gene.


Keywords: Endoscopic Ultrasound-Guided Fine Needle Aspiration; Lung Neoplasms; Mediastinum; Lymph node; Neoplasm Metastasis

Go to:

Figures


	Fig. 1 EBUS bronchoscope and puncture needle. (A) Tip of ultrasound puncture bronchoscope. (B) Inflated balloon with saline and 22-guaze TBNA needle.
	Click for larger image


	Fig. 2 Ultrasound images of EBUS-TBNA procedures. (A) Linear ultrasound image (needle in the lymph node) is a 50° slice in parallel to the long axis of the bronchoscope. (B) Power Doppler image can differentiate the vascular shadow (PA & AO) from lymph node (4L).
	Click for larger image


	Fig. 3 CP-EBUS-TBNA for the central parenchymal lung mass. (A) Lung parenchymal mass at right upper lobe which abuts the trachea. (B) Linear ultrasound image of the mass (needle in the mass).
	Click for larger image

Go to:

References


1.	Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10–29.

2.	Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e211S–e250S.

3.	De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32:1–8.

4.	Hurter T, Hanrath P. Endobronchial sonography: feasibility and preliminary results. Thorax 1992;47:565–567.

5.	Steinfort DP, Khor YH, Manser RL, Irving LB. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. Eur Respir J 2011;37:902–910.

6.	Yasufuku K, Nakajima T, Chiyo M, Sekine Y, Shibuya K, Fujisawa T. Endobronchial ultrasonography: current status and future directions. J Thorac Oncol 2007;2:970–979.

7.	Yasufuku K, Chiyo M, Koh E, Moriya Y, Iyoda A, Sekine Y, et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005;50:347–354.

8.	Lee HS, Lee GK, Kim MS, Lee JM, Kim HY, Nam BH, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest 2008;134:368–374.

9.	Lazzari Agli L, Trisolini R, Burzi M, Patelli M. Mediastinal hematoma following transbronchial needle aspiration. Chest 2002;122:1106–1107.

*10.*	Aerts JG, Kloover J, Los J, van der Heijden O, Janssens A, Tournoy KG. EUS-FNA of enlarged necrotic lymph nodes may cause infectious mediastinitis. J Thorac Oncol 2008;3:1191–1193.

*11.*	Gupta R, Park HY, Kim H, Um SW. Endobronchial inflammatory polyp as a rare complication of endobronchial ultrasound-transbronchial needle aspiration. Interact Cardiovasc Thorac Surg 2010;11:340–341.

*12.*	Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H, Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J 2006;28:910–914.

*13.*	Hwangbo B, Kim SK, Lee HS, Kim MS, Lee JM, Kim HY, et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2009;135:1280–1287.

*14.*	Szlubowski A, Kuzdzal J, Kolodziej M, Soja J, Pankowski J, Obrochta A, et al. Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging. Eur J Cardiothorac Surg 2009;35:332–335. discussion 5-6.

*15.*	Yasufuku K, Nakajima T, Motoori K, Sekine Y, Shibuya K, Hiroshima K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 2006;130:710–718.

*16.*	Yasufuku K, Chiyo M, Sekine Y, Chhajed PN, Shibuya K, Iizasa T, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest 2004;126:122–128.

*17.*	Jhun BW, Park HY, Jeon K, Koh WJ, Suh GY, Chung MP, et al. Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer. J Korean Med Sci 2012;27:46–51.

*18.*	Ernst A, Anantham D, Eberhardt R, Krasnik M, Herth FJ. Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol 2008;3:577–582.

*19.*	Yasufuku K, Pierre A, Darling G, de Perrot M, Waddell T, Johnston M, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011;142:1393–1400.e1.

*20.*	Um SW, Lee KJ, Kim HK, Choi YS, Kim JK, Shim YM, et al. A prospective study of endobronchial ultrasound-Guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal nodal staging of non-small cell lung cancer. Am J Respir Crit Care Med 2013;187:A3591.

*21.*	Annema JT, van Meerbeeck JP, Rintoul RC, Dooms C, Deschepper E, Dekkers OM, et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010;304:2245–2252.

*22.*	Wallace MB, Pascual JM, Raimondo M, Woodward TA, McComb BL, Crook JE, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008;299:540–546.

*23.*	Herth FJ, Krasnik M, Kahn N, Eberhardt R, Ernst A. Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer. Chest 2010;138:790–794.

*24.*	Hwangbo B, Lee GK, Lee HS, Lim KY, Lee SH, Kim HY, et al. Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest 2010;138:795–802.

*25.*	Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009;374:379–386.

*26.*	Herth FJ, Annema JT, Eberhardt R, Yasufuku K, Ernst A, Krasnik M, et al. Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol 2008;26:3346–3350.

*27.*	Szlubowski A, Herth FJ, Soja J, Kolodziej M, Figura J, Cmiel A, et al. Endobronchial ultrasound-guided needle aspiration in non-small-cell lung cancer restaging verified by the transcervical bilateral extended mediastinal lymphadenectomy--a prospective study. Eur J Cardiothorac Surg 2010;37:1180–1184.

*28.*	Tournoy KG, Rintoul RC, van Meerbeeck JP, Carroll NR, Praet M, Buttery RC, et al. EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy. Lung Cancer 2009;63:45–49.

*29.*	Nakajima T, Yasufuku K, Fujiwara T, Chiyo M, Sekine Y, Shibuya K, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrapulmonary lesions. J Thorac Oncol 2008;3:985–988.

*30.*	Verma A, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of central lung parenchymal lesions. Yonsei Med J 2013;54:672–678.

*31.*	Han SG, Yoo H, Jhun BW, Park HY, Suh GY, Chung MP, et al. The role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of recurrent non-small cell lung cancer after surgery. Intern Med 2013;52:1875–1881.

*32.*	Nakajima T, Yasufuku K, Suzuki M, Hiroshima K, Kubo R, Mohammed S, et al. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration. Chest 2007;132:597–602.

*33.*	Nakajima T, Yasufuku K, Nakagawara A, Kimura H, Yoshino I. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Chest 2011;140:1319–1324.

*34.*	Sakairi Y, Nakajima T, Yasufuku K, Ikebe D, Kageyama H, Soda M, et al. EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Clin Cancer Res 2010;16:4938–4945.

*35.*	Kang YR, Park HY, Jeon K, Koh WJ, Suh GY, Chung MP, et al. EGFR and KRAS mutation analyses from specimens obtained by bronchoscopy and EBUS-TBNA. Thorac Cancer 2013;4:264–272.